Polytetrafluoroethylene-encapsulated stent-grafts

Use in experimental abdominal aortic aneurysm

Amy E. Benson, Julio C. Palmaz, Fermin O. Tio, Eugene A. Sprague, Carlos E. Encarnacion, Shellie C. Josephs

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

PURPOSE: To evaluate expanded polytetrafluoroethylene (ePTFE) encapsulated stents for the treatment of aortic aneurysms with emphasis on the blood and tissue, material interactions. MATERIALS AND METHODS: Experimental aortic aneurysms were created in dogs by enlarging the aortic lumen with an abdominal fascial patch. Twenty animals underwent endoluminal repair after allowing the surgically created aneurysm to heal for 2 months prior to transluminal aneurysmal exclusion. The device used consisted of an 8-cm-long ePTFE encapsulated stent graft. The animals were killed in groups at 1 week and at 1, 2.25, 6, and 12 months. Specimens were processed for histologic and luminal surface studies. RESULTS: Before the animals were killed, aortography demonstrated two thrombosed aortae in the 6-month group and two endoleaks in the 12-month group. Endothelialized neointima extended into the proximal and distal portions of the prosthetic lumen, with minimal cell coverage in the center of the graft. The overall percent surface area covered by endothelialized neointima was 22% ± 6% at 6 months and 18% ± 10% by 1 year (P = .75). Histologic examination demonstrated minimal tissue penetration into the ePTFE. CONCLUSION: Transluminal exclusion of abdominal aortic aneurysms by encapsulated stent-graft is easily accomplished. With this device, tissue coverage and penetration of the stent graft is limited and does not tend to increase with time.

Original languageEnglish (US)
Pages (from-to)605-612
Number of pages8
JournalJournal of Vascular and Interventional Radiology
Volume10
Issue number5
StatePublished - May 1999

Fingerprint

Abdominal Aortic Aneurysm
Polytetrafluoroethylene
Stents
Transplants
Neointima
Aortic Aneurysm
Endoleak
Aortography
Equipment and Supplies
Angioplasty
Aneurysm
Aorta
Thrombosis
Dogs
Therapeutics

Keywords

  • Aneurysm, therapy
  • Aorta, aneurysm
  • Endovascular stent grafts
  • Stents and prostheses

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Polytetrafluoroethylene-encapsulated stent-grafts : Use in experimental abdominal aortic aneurysm. / Benson, Amy E.; Palmaz, Julio C.; Tio, Fermin O.; Sprague, Eugene A.; Encarnacion, Carlos E.; Josephs, Shellie C.

In: Journal of Vascular and Interventional Radiology, Vol. 10, No. 5, 05.1999, p. 605-612.

Research output: Contribution to journalArticle

Benson, Amy E. ; Palmaz, Julio C. ; Tio, Fermin O. ; Sprague, Eugene A. ; Encarnacion, Carlos E. ; Josephs, Shellie C. / Polytetrafluoroethylene-encapsulated stent-grafts : Use in experimental abdominal aortic aneurysm. In: Journal of Vascular and Interventional Radiology. 1999 ; Vol. 10, No. 5. pp. 605-612.
@article{acbcde5762a6453293fbbbfa2a40b825,
title = "Polytetrafluoroethylene-encapsulated stent-grafts: Use in experimental abdominal aortic aneurysm",
abstract = "PURPOSE: To evaluate expanded polytetrafluoroethylene (ePTFE) encapsulated stents for the treatment of aortic aneurysms with emphasis on the blood and tissue, material interactions. MATERIALS AND METHODS: Experimental aortic aneurysms were created in dogs by enlarging the aortic lumen with an abdominal fascial patch. Twenty animals underwent endoluminal repair after allowing the surgically created aneurysm to heal for 2 months prior to transluminal aneurysmal exclusion. The device used consisted of an 8-cm-long ePTFE encapsulated stent graft. The animals were killed in groups at 1 week and at 1, 2.25, 6, and 12 months. Specimens were processed for histologic and luminal surface studies. RESULTS: Before the animals were killed, aortography demonstrated two thrombosed aortae in the 6-month group and two endoleaks in the 12-month group. Endothelialized neointima extended into the proximal and distal portions of the prosthetic lumen, with minimal cell coverage in the center of the graft. The overall percent surface area covered by endothelialized neointima was 22{\%} ± 6{\%} at 6 months and 18{\%} ± 10{\%} by 1 year (P = .75). Histologic examination demonstrated minimal tissue penetration into the ePTFE. CONCLUSION: Transluminal exclusion of abdominal aortic aneurysms by encapsulated stent-graft is easily accomplished. With this device, tissue coverage and penetration of the stent graft is limited and does not tend to increase with time.",
keywords = "Aneurysm, therapy, Aorta, aneurysm, Endovascular stent grafts, Stents and prostheses",
author = "Benson, {Amy E.} and Palmaz, {Julio C.} and Tio, {Fermin O.} and Sprague, {Eugene A.} and Encarnacion, {Carlos E.} and Josephs, {Shellie C.}",
year = "1999",
month = "5",
language = "English (US)",
volume = "10",
pages = "605--612",
journal = "Journal of Vascular and Interventional Radiology",
issn = "1051-0443",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Polytetrafluoroethylene-encapsulated stent-grafts

T2 - Use in experimental abdominal aortic aneurysm

AU - Benson, Amy E.

AU - Palmaz, Julio C.

AU - Tio, Fermin O.

AU - Sprague, Eugene A.

AU - Encarnacion, Carlos E.

AU - Josephs, Shellie C.

PY - 1999/5

Y1 - 1999/5

N2 - PURPOSE: To evaluate expanded polytetrafluoroethylene (ePTFE) encapsulated stents for the treatment of aortic aneurysms with emphasis on the blood and tissue, material interactions. MATERIALS AND METHODS: Experimental aortic aneurysms were created in dogs by enlarging the aortic lumen with an abdominal fascial patch. Twenty animals underwent endoluminal repair after allowing the surgically created aneurysm to heal for 2 months prior to transluminal aneurysmal exclusion. The device used consisted of an 8-cm-long ePTFE encapsulated stent graft. The animals were killed in groups at 1 week and at 1, 2.25, 6, and 12 months. Specimens were processed for histologic and luminal surface studies. RESULTS: Before the animals were killed, aortography demonstrated two thrombosed aortae in the 6-month group and two endoleaks in the 12-month group. Endothelialized neointima extended into the proximal and distal portions of the prosthetic lumen, with minimal cell coverage in the center of the graft. The overall percent surface area covered by endothelialized neointima was 22% ± 6% at 6 months and 18% ± 10% by 1 year (P = .75). Histologic examination demonstrated minimal tissue penetration into the ePTFE. CONCLUSION: Transluminal exclusion of abdominal aortic aneurysms by encapsulated stent-graft is easily accomplished. With this device, tissue coverage and penetration of the stent graft is limited and does not tend to increase with time.

AB - PURPOSE: To evaluate expanded polytetrafluoroethylene (ePTFE) encapsulated stents for the treatment of aortic aneurysms with emphasis on the blood and tissue, material interactions. MATERIALS AND METHODS: Experimental aortic aneurysms were created in dogs by enlarging the aortic lumen with an abdominal fascial patch. Twenty animals underwent endoluminal repair after allowing the surgically created aneurysm to heal for 2 months prior to transluminal aneurysmal exclusion. The device used consisted of an 8-cm-long ePTFE encapsulated stent graft. The animals were killed in groups at 1 week and at 1, 2.25, 6, and 12 months. Specimens were processed for histologic and luminal surface studies. RESULTS: Before the animals were killed, aortography demonstrated two thrombosed aortae in the 6-month group and two endoleaks in the 12-month group. Endothelialized neointima extended into the proximal and distal portions of the prosthetic lumen, with minimal cell coverage in the center of the graft. The overall percent surface area covered by endothelialized neointima was 22% ± 6% at 6 months and 18% ± 10% by 1 year (P = .75). Histologic examination demonstrated minimal tissue penetration into the ePTFE. CONCLUSION: Transluminal exclusion of abdominal aortic aneurysms by encapsulated stent-graft is easily accomplished. With this device, tissue coverage and penetration of the stent graft is limited and does not tend to increase with time.

KW - Aneurysm, therapy

KW - Aorta, aneurysm

KW - Endovascular stent grafts

KW - Stents and prostheses

UR - http://www.scopus.com/inward/record.url?scp=0032901687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032901687&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 605

EP - 612

JO - Journal of Vascular and Interventional Radiology

JF - Journal of Vascular and Interventional Radiology

SN - 1051-0443

IS - 5

ER -